STATE STREET CORP - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 194 filers reported holding SAGE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$90,108,851
-16.6%
4,378,467
+90.4%
0.01%
-16.7%
Q2 2023$108,105,563
-5.8%
2,299,140
-15.9%
0.01%0.0%
Q1 2023$114,734,230
-44.8%
2,734,373
-49.9%
0.01%0.0%
Q4 2022$208,038,138
+79.8%
5,454,592
+84.6%
0.01%
-14.3%
Q3 2022$115,705,000
+22.1%
2,954,683
+0.7%
0.01%
+16.7%
Q2 2022$94,770,000
+1.0%
2,934,064
+3.5%
0.01%
+20.0%
Q1 2022$93,850,000
+1.7%
2,835,356
+30.8%
0.01%
+25.0%
Q4 2021$92,249,000
+5.4%
2,168,530
+9.7%
0.00%
-20.0%
Q3 2021$87,554,000
+15.3%
1,975,952
+47.8%
0.01%
+25.0%
Q2 2021$75,941,000
-19.3%
1,336,758
+6.3%
0.00%
-20.0%
Q1 2021$94,116,000
-29.0%
1,257,390
-18.0%
0.01%
-37.5%
Q4 2020$132,609,000
+45.8%
1,532,879
+3.0%
0.01%
+33.3%
Q3 2020$90,971,000
+3.3%
1,488,399
-29.7%
0.01%0.0%
Q2 2020$88,039,000
+81.9%
2,117,336
+25.6%
0.01%
+50.0%
Q1 2020$48,397,000
-59.6%
1,685,134
+1.6%
0.00%
-50.0%
Q4 2019$119,682,000
-17.9%
1,657,872
+59.5%
0.01%
-27.3%
Q3 2019$145,845,000
-16.6%
1,039,599
+8.8%
0.01%
-15.4%
Q2 2019$174,935,000
+5.1%
955,461
-8.7%
0.01%0.0%
Q1 2019$166,437,000
+63.8%
1,046,444
-1.4%
0.01%
+44.4%
Q4 2018$101,617,000
-28.5%
1,060,834
+5.5%
0.01%
-18.2%
Q3 2018$142,035,000
-9.0%
1,005,545
+0.8%
0.01%
-15.4%
Q2 2018$156,128,000
-21.4%
997,406
-19.1%
0.01%
-23.5%
Q1 2018$198,626,000
+7.3%
1,233,178
+9.7%
0.02%
+13.3%
Q4 2017$185,084,000
+139.0%
1,123,672
-9.6%
0.02%
+114.3%
Q3 2017$77,427,000
-19.8%
1,242,765
+2.5%
0.01%
-22.2%
Q2 2017$96,558,000
+20.7%
1,212,384
+7.7%
0.01%
+28.6%
Q1 2017$79,976,000
+35.3%
1,125,287
-2.8%
0.01%
+16.7%
Q4 2016$59,107,000
+9.7%
1,157,665
-1.1%
0.01%
+20.0%
Q3 2016$53,904,000
+92.5%
1,170,501
+25.9%
0.01%
+66.7%
Q2 2016$28,002,000
+20.5%
929,473
+28.2%
0.00%0.0%
Q1 2016$23,245,000
-25.0%
724,957
+36.3%
0.00%0.0%
Q4 2015$31,011,000
+17.3%
531,935
-14.9%
0.00%0.0%
Q3 2015$26,438,000
-24.8%
624,724
+29.7%
0.00%
-25.0%
Q2 2015$35,177,000
+835.3%
481,815
+542.9%
0.00%
Q1 2015$3,761,000
+41.0%
74,944
+2.8%
0.00%
Q4 2014$2,668,000
+76.1%
72,872
+51.5%
0.00%
Q3 2014$1,515,00048,1000.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 5,149,482$105,976,3402.24%
Palo Alto Investors LP 1,005,776$20,698,8701.96%
Boxer Capital, LLC 1,094,000$22,514,5201.20%
Bellevue Group AG 3,513,351$72,304,7641.16%
PDT Partners, LLC 181,625$3,737,8430.47%
EASTERLY INVESTMENT PARTNERS LLC 195,643$4,026,3330.44%
Harvest Investment Services, LLC 30,302$623,6150.40%
Simplify Asset Management Inc. 120,030$2,470,2170.28%
SAMLYN CAPITAL, LLC 739,867$15,226,4630.25%
CAXTON ASSOCIATES LP 68,035$1,400,1600.19%
View complete list of SAGE THERAPEUTICS INC shareholders